Wednesday, August 12, 2015 11:43:39 AM
Thank you Matija for taking time to write this very eloquent piece that show how outrageously poor the other article - the hit piece - was. Cellceutix is of course high risk. Investing in biotech is per definition high risk. But if you understand the science and invest a lot of time doing dd then there is also high reward as you write. Only few companies hold an upside as big as CTIX at the curent valutation but of course there is still risk. Thank you for being the voice of reason and for sharing your expertice. Hopefully, people will see who is most trustworty: An anonymous writer with an anonymous "scientist" as his side kick or you, the FDA, Dana Farber, Dr. Shapiro, University of Bologna, Dr. Emil Frei - and the company, of course.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM